Literature DB >> 21224146

Recent advances in the development of animal and cell culture models for prostate cancer research A minireview.

M C Bosland1, L W Chung, N M Greenberg, S M Ho, J T Isaacs, K Lane, D M Peehl, T C Thompson, G J van Steenbrugge, W M van Weerden.   

Abstract

Entities:  

Year:  1996        PMID： 21224146     DOI： 10.1016/s1078-1439(96)00077-4

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  5 in total

1.  Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Valerie Odero-Marah; Cimona V Hinton
Journal:  Mol Cancer Res       Date:  2010-11-12       Impact factor: 5.852

2.  Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.

Authors:  H W Rhee; H E Zhau; S Pathak; A S Multani; S Pennanen; T Visakorpi; L W Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-03       Impact factor: 2.723

Review 3.  Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer.

Authors:  W M van Weerden; C Bangma; R de Wit
Journal:  Br J Cancer       Date:  2008-12-16       Impact factor: 7.640

4.  Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3.

Authors:  James Robert Krycer; Ika Kristiana; Andrew John Brown
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

5.  Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer.

Authors:  Jingxuan Shan; Mariam A Al-Muftah; Moza K Al-Kowari; Sirin W J Abuaqel; Khalid Al-Rumaihi; Issam Al-Bozom; Pu Li; Lotfi Chouchane
Journal:  Cell Death Discov       Date:  2019-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.